Toxicity of TNF alpha and platelet activating factor for human NT2N neurons: a tissue culture model for human immunodeficiency virus dementia
- PMID: 8799203
- DOI: 10.3109/13550289609146545
Toxicity of TNF alpha and platelet activating factor for human NT2N neurons: a tissue culture model for human immunodeficiency virus dementia
Abstract
A significant proportion of HIV-1 infected individuals develop a symptom complex consisting of dementia and motor deficits termed HIV Dementia (HIVD) or the AIDS Dementia complex (ADC). The pathophysiology of this neurologic complication is unclear, but neuronal injury and death may occur as a direct result of the release of cytokines from HIV-1 infected microglial cells (Everall et al, 1991). To evaluate the utility of a human neuronal cell line, NT2N, for studies of HIV-related neuronal cytotoxicity, we studied cellular viability after exposure to HIV-1 gp120, tumor necrosis factor alpha (TFN alpha), platelet activating factor (PAF), interleukin 1 beta (IL-1 beta), and interferon gamma (IFN gamma), all of which have been implicated in previous publications as having a role in HIVD (Brenneman et al, 1988; Dreyer et al, 1990; Merrill et al, 1992; Gelbard et al, 1993). Neither gp 120 nor the cytokines IL-1 beta and IFN gamma resulted in significant NT2N cell death. However, TNF alpha and PAF were highly neurotoxic in this assay. Pentoxifylline, which inhibits the effects of TNF alpha, had a significant protective effect. This system provides an excellent substrate for the evaluation of neurotoxicity and for the development of pharmacologic agents that may be useful in HIV dementia.
Similar articles
-
Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases.Adv Neuroimmunol. 1995;5(3):335-58. doi: 10.1016/0960-5428(95)00012-q. Adv Neuroimmunol. 1995. PMID: 8748077 Review.
-
HIV-1B gp120 genes from one patient with AIDS dementia complex can affect the secretion of tumor necrosis factor and interleukin 1β in glial cells.Chin Med J (Engl). 2011 Dec;124(24):4217-22. Chin Med J (Engl). 2011. PMID: 22340390
-
Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin.J Virol. 1994 Jul;68(7):4628-35. doi: 10.1128/JVI.68.7.4628-4635.1994. J Virol. 1994. PMID: 8207837 Free PMC article.
-
Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species.Brain Pathol. 1996 Oct;6(4):507-17. doi: 10.1111/j.1750-3639.1996.tb00879.x. Brain Pathol. 1996. PMID: 8944320 Review.
-
AIDS-related dementia and calcium homeostasis.Ann N Y Acad Sci. 1994 Dec 15;747:205-24. doi: 10.1111/j.1749-6632.1994.tb44411.x. Ann N Y Acad Sci. 1994. PMID: 7847672 Review.
Cited by
-
Role of micronutrients in the modulation of immune system and platelet activating factor in patients with COVID-19; a narrative review.Front Nutr. 2023 Sep 15;10:1207237. doi: 10.3389/fnut.2023.1207237. eCollection 2023. Front Nutr. 2023. PMID: 37781112 Free PMC article. Review.
-
Growth-associated protein-43 and ephrin B3 induction in the brain of adult SIV-infected rhesus macaques.J Neurovirol. 2011 Oct;17(5):455-68. doi: 10.1007/s13365-011-0047-0. Epub 2011 Jul 26. J Neurovirol. 2011. PMID: 21789725 Free PMC article.
-
Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity.Neurobiol Dis. 2007 Jun;26(3):661-70. doi: 10.1016/j.nbd.2007.03.004. Epub 2007 Mar 20. Neurobiol Dis. 2007. PMID: 17451964 Free PMC article.
-
Differences in cytokine and chemokine responses during neurological disease induced by polytropic murine retroviruses Map to separate regions of the viral envelope gene.J Virol. 2001 Mar;75(6):2848-56. doi: 10.1128/JVI.75.6.2848-2856.2001. J Virol. 2001. PMID: 11222710 Free PMC article.
-
Hydrogen Sulfide Protects Hippocampal Neurons Against Methamphetamine Neurotoxicity Via Inhibition of Apoptosis and Neuroinflammation.J Mol Neurosci. 2019 Jan;67(1):133-141. doi: 10.1007/s12031-018-1218-8. Epub 2018 Nov 19. J Mol Neurosci. 2019. PMID: 30456731